Mallinckrodt snaps up Sucampo for $1.2bn
UK-based pharma Mallinckrodt is buying US biopharma Sucampo Pharmaceuticals for around $1.2 billion.
Read More
Tag: Sucampo
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
